Longer-acting preexposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment
Results suggest high demand for LA-PrEP among populations with disproportionately high HIV incidence. To facilitate use, programs should offer a range of LA-PrEP products, minimize out-of-pocket costs, and counsel on side effects.
Authors
- Damian J. Denson (ORCID: https://orcid.org/0000-0002-1643-4634)
- Erica N. Browne (ORCID: https://orcid.org/0000-0003-2069-6589)
- Alexandra M. Minnis (ORCID: https://orcid.org/0000-0002-2943-2005)
- Karen W. Hoover (ORCID: https://orcid.org/0000-0003-4942-7905)
- Rupa Patel (ORCID: https://orcid.org/0000-0002-0329-7036)
- Sarah T. Roberts (ORCID: https://orcid.org/0000-0002-3318-9781)
- Athena P. Kourtis (ORCID: https://orcid.org/0000-0003-1585-1310)
- Noah Mancuso (ORCID: https://orcid.org/0000-0002-4442-9293)
- Jackie Mungo
- Emily Moore (ORCID: https://orcid.org/0000-0002-4099-157X)
- Miranda Diaz
Institutions
- Centers for Disease Control and Prevention (US)
- RTI International (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
Publication Details
- Journal
- AIDS
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1097/qad.0000000000004247
- Citations
- 2
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 2.79